Allergenic extracts modified with glutaraldehyde (polymerized), adsorbed onto aluminum hydroxide gel for specific immunotherapy. Polymerization reduces the IgE binding of allergens to IgE while maintaining their immunogenicity, allowing a safer and quicker up-dosing.
Active substance: polymerized allergenic extracts (enviromental inhalants) formulated under medical prescription. Excipients: aluminum hydroxide, sodium chloride, phenol and water for injection.
Inmunotek standarizes its allergenic extracts in biological units (BU) following the Nordic guidelines. The biological concentration of extracts used in Alxoid® is given in Therapeutic Units (TU)/mL. 10,000 TU/mL are equivalent in protein to 10,000 BU/mL of the same non-modified extract.
Rhinitis, conjunctivitis and/or asthma due to type 1 hypersensitivity (IgE-mediated) caused by available allergens.
Vial A. Silver label. Concentration 2.000 UT/mL. Volume 1.5 mL
Vial B. Blue label. Concentration 10.000 UT/mL. Volume 2.5 mL